CONMED | CNMD - Betriebsergebnis

Aktienkurs
35.94
Täglich Wechseln
-0.86 -2.34%
Monatlich
-20.80%
Jährlich
-39.74%
Q1 Prognose
34.86




Betriebsergebnis Veränderung Datum
3M USD 1.21B 394M 2025-12
Abbott USD 2.25B 73M 2025-12
Accuray USD 4.71M 6.86M 2024-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
CONMED USD 36.62M 24.74M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Hologic USD 237M 16M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 5.59B 1.81B 2025-12
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Olympus JPY 28B 5.56B 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Smith & Nephew USD 440M 50M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12